EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Unlocking the therapeutic potential of ATR inhibitors: Advances, challenges, and opportunities in cancer therapy

Tejaswini P Reddy iD, Timothy A Yap

Clinical and Translational Medicine · 2025-07 · 15 (7)

DOI: 10.1002/ctm2.70397 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical and Translational Medicine, online erschienen am 17.07.2025. Verfasst von Tejaswini P Reddy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Tejaswini P Reddy

Zitieren

APA

Reddy, T. P., & Yap, T. A. (2025). Unlocking the therapeutic potential of ATR inhibitors: Advances, challenges, and opportunities in cancer therapy. Clinical and Translational Medicine, 15(7). https://doi.org/10.1002/ctm2.70397

Vancouver

Reddy TP, Yap TA. Unlocking the therapeutic potential of ATR inhibitors: Advances, challenges, and opportunities in cancer therapy. Clinical and Translational Medicine. 2025;15(7). doi:10.1002/ctm2.70397

BibTeX
@article{Reddy2025,
  author = {Reddy, Tejaswini P and Yap, Timothy A},
  title = {Unlocking the therapeutic potential of ATR inhibitors: Advances, challenges, and opportunities in cancer therapy},
  journal = {Clinical and Translational Medicine},
  year = {2025},
  volume = {15},
  number = {7},
  doi = {10.1002/ctm2.70397}
}
Kostenlos starten →